Comparative Effectiveness of Resection vs Surveillance for Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasms With Worrisome Features

作者: Victor M. Zaydfudim , Yinin Hu , Lily E. Johnston , Vanessa M. Shami , Todd W. Bauer

DOI: 10.1001/JAMASURG.2017.4587

关键词:

摘要: Importance The 2012 international consensus guidelines defined a subcategory of pancreatic branch duct intraductal papillary mucinous neoplasms with “worrisome features,” which may be followed close surveillance. However, given the poor prognosis invasive malignancy, role early, upfront resection requires further investigation. Objective To compare utility vs long-term We hypothesized that surveillance these cystic would offer greater utility. Design, Setting, and Participants A Markov decision analysis model was constructed to estimate 2 management strategies: early Estimates for outcomes, probabilities transitions between disease states, surgical morbidity were derived from literature review articles published 1997 2014. comparative effectiveness model’s variable estimates based on data predominantly by high-volume, tertiary referral centers. Model probability large, retrospective, single-institution reports. For variables, studies using standard-gamble or time-tradeoff methods weight. Main Outcomes Measures Expected measured in terms quality-adjusted life years 3% annual discount. Probabilistic 1-way sensitivity analyses performed assess potential effects uncertainty key variables. Results Early yielded 11.63 life-years during 20 follow-up compared 11.06 indicated has 94% likelihood being more effective than obtained only if each following criteria are met: expectancy is at least 18 years, mortality less 4.3%, baseline preoperative 0.78. Additional drivers outcomes include rate progression worrisome high-risk features finding cancer stigmata. Conclusions Relevance compares favorably features. careful consideration patient factors surgeon imperative.

参考文章(43)
James D. Murphy, Daniel T. Chang, Jon Abelson, Megan E. Daly, Heidi N. Yeung, Lorene M. Nelson, Albert C. Koong, Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer Cancer. ,vol. 118, pp. 1119- 1129 ,(2012) , 10.1002/CNCR.26365
Felix J Hüttner, Christina Fitzmaurice, Guido Schwarzer, Christoph M Seiler, Gerd Antes, Markus W Büchler, Markus K Diener, Pylorus‐preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma Cochrane Database of Systematic Reviews. ,vol. 2, pp. 0- 0 ,(2016) , 10.1002/14651858.CD006053.PUB6
Takuya Mimura, Atsuhiro Masuda, Ippei Matsumoto, Hideyuki Shiomi, Shiei Yoshida, Maki Sugimoto, Tsuyoshi Sanuki, Masaru Yoshida, Tsuyoshi Fujita, Hiromu Kutsumi, Yonsou Ku, Takeshi Azuma, Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. Journal of Clinical Gastroenterology. ,vol. 44, pp. 224- 229 ,(2010) , 10.1097/MCG.0B013E3181D8FB91
C Max Schmidt, Patrick B. White, Joshua A. Waters, Constantin T. Yiannoutsos, Oscar W. Cummings, Marshall Baker, Thomas J. Howard, Nicholas J. Zyromski, Atilla Nakeeb, John M. DeWitt, Fatih M. Akisik, Stuart Sherman, Henry A. Pitt, Keith D. Lillemoe, Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Annals of Surgery. ,vol. 246, pp. 644- 654 ,(2007) , 10.1097/SLA.0B013E318155A9E5
Charles J. Yeo, John L. Cameron, Taylor A. Sohn, Keith D. Lillemoe, Henry A. Pitt, Mark A. Talamini, Ralph H. Hruban, Sarah E. Ord, Patricia K. Sauter, JoAnn Coleman, Marianna L. Zahurak, Louise B. Grochow, Ross A. Abrams, Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Annals of Surgery. ,vol. 226, pp. 248- 260 ,(1997) , 10.1097/00000658-199709000-00004
Klaus Sahora, Mari Mino-Kenudson, William Brugge, Sarah P. Thayer, Cristina R. Ferrone, Dushyant Sahani, Martha B. Pitman, Andrew L. Warshaw, Keith D. Lillemoe, Carlos F. Fernandez-del Castillo, Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Annals of Surgery. ,vol. 258, pp. 466- 475 ,(2013) , 10.1097/SLA.0B013E3182A18F48
John J. Huang, Charles J. Yeo, Taylor A. Sohn, Keith D. Lillemoe, Patricia K. Sauter, JoAnn Coleman, Ralph H. Hruban, John L. Cameron, Quality of life and outcomes after pancreaticoduodenectomy. Annals of Surgery. ,vol. 231, pp. 890- 898 ,(2000) , 10.1097/00000658-200006000-00014
Dorothy Romanus, Hedy L Kindler, Laura Archer, Ethan Basch, Donna Niedzwiecki, Jane Weeks, Deborah Schrag, Cancer and Leukemia Group B, Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) Journal of Pain and Symptom Management. ,vol. 43, pp. 205- 217 ,(2012) , 10.1016/J.JPAINSYMMAN.2011.09.001
Yoshihiko Sadakari, Jun Ienaga, Kiichiro Kobayashi, Yoshihiro Miyasaka, Shunichi Takahata, Masafumi Nakamura, Kazuhiro Mizumoto, Masao Tanaka, Cyst Size Indicates Malignant Transformation in Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas Without Mural Nodules Pancreas. ,vol. 39, pp. 232- 236 ,(2010) , 10.1097/MPA.0B013E3181BAB60E
Edward S. Huang, G. Scott Gazelle, Chin Hur, Consensus Guidelines in the Management of Branch Duct Intraductal Papillary Mucinous Neoplasm: A Cost-Effectiveness Analysis Digestive Diseases and Sciences. ,vol. 55, pp. 852- 860 ,(2010) , 10.1007/S10620-009-1014-Y